Drugs / PRP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02561520 | Dec 2016 → Sep 2018 | graft versus host disease | Ladan Espandar | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02561520 ↗ |
| Route | Topical | “Eye drops 4x a day, patients will start this eye drop first.” NCT02561520 ↗ |